Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-09 · accession 0001628280-22-029866 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-14 | 2022-11-09 | AUPH | Habig Scott Michael | Chief Commercial Off | P - Purchase | $5.02 | +5,000 | 5,000 | New | +$25.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-09 | P | A | 5,000 | $5.02 | 5,000 | D | — | — |